GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ELAN · Sep 30, 2025

Elanco Animal Health Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001739104-25-000071General Corporate
Debt relative to revenue30thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

331.49% · OPTIONAL · VALID

Capex intensity100thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

8.09% · OPTIONAL · VALID

Operating cash generation95thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

19.26% · OPTIONAL · VALID

Revenue growth70thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

10.39% · CORE · VALID

Inventory pressure80thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

150.22% · OPTIONAL · VALID

Gross margin15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

53.39% · CORE · VALID

R&D intensity70thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

7.83% · OPTIONAL · VALID

SBC intensity90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.50% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20237/7 normalizedLevel 3Sep 30, 20237/7 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
318.61%
Current
331.49%
Delta
12.87%
Capex Intensity Increased
Previous
4.59%
Current
8.09%
Delta
3.50%
Cash Generation Increased
Previous
19.10%
Current
19.26%
Delta
0.16%
Growth Increased
Previous
4.81%
Current
10.39%
Delta
5.57%
Inventory Pressure Increased
Previous
134.57%
Current
150.22%
Delta
15.65%
Margin Decreased
Previous
57.45%
Current
53.39%
Delta
-4.07%
R And D Intensity Increased
Previous
7.41%
Current
7.83%
Delta
0.41%
Sbc Intensity Decreased
Previous
1.61%
Current
1.50%
Delta
-0.12%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ELAN Fundamental State →Has State · Elanco Animal Health Inc →Transitioned To · ELAN Fundamental State →Transitioned To · ELAN BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · ELAN CAPEX_INTENSITY_INCREASED →Transitioned To · ELAN CASH_GENERATION_INCREASED →Transitioned To · ELAN GROWTH_INCREASED →Transitioned To · ELAN INVENTORY_PRESSURE_INCREASED →Transitioned To · ELAN MARGIN_DECREASED →Transitioned To · ELAN R_AND_D_INTENSITY_INCREASED →Transitioned To · ELAN SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.